SCHEMBL7319086

SCHEMBL7319086

CC(=O)Cc1nc(CN2CCCCC2)no1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.42
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ BMP1 P13497 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ MAPT P10636 1/20 0.39
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ CYP3A4 P08684 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ HRH3 Q9Y5N1 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14374414 0.79 ALDH1A1 (0.48) TP53NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL265221 0.74 KDM4E (0.36) L3MBTL1
SCHEMBL12963698 0.73 NPC1 (0.52) NPC1RAB9ASMN1; SMN2ALDH1A1CYP1A2
SCHEMBL22229890 0.73 BMP1 (0.41) TP53NPC1RAB9ASMN1; SMN2BMP1
SCHEMBL12626 0.73 NPC1 (0.44) NPC1RAB9ASMN1; SMN2BMP1ALDH1A1
SCHEMBL7317347 0.73 SMPD1 (0.32) L3MBTL1
SCHEMBL14034348 0.69 BMP1 (0.45) NPC1RAB9ASMN1; SMN2BMP1CYP1A2
SCHEMBL14006362 0.69 TSHR (0.41) NPC1RAB9ASMN1; SMN2BMP1ALDH1A1
SCHEMBL7263917 0.67 HSD17B10 (0.42) TP53RAB9ASMN1; SMN2ALDH1A1MAPT
SCHEMBL2888294 0.67 MAPT (0.43) SMN1; SMN2MAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4705786-A Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1987-11-10 — — US disclosed
Send feedback